Some factors clearly influenced the rate of engraftment: squamous histology, poor differentiation and larger tumor size favored engraftment; importantly, the engraftment was preferential for KRAS-mutated tumors, compared to EGFR-mutated tumors [210]. This evidence concerns the gene KRAS and neoplasm.